A UCLA cancer study reported in this month's Nature Nanotechnology validates earlier work by MIT engineers, and is emblematic of an explosion in research at the intersections of engineering, the life sciences and medicine, according to MIT Dean of Engineering Subra Suresh.
Northwest Biotherapeutics Inc. said in a Securities and Exchange Commission filing that Peterson Sullivan PLLC has replaced KPMG LLP as Northwest's independent auditor.
ImClone Systems and Bristol-Myers Squibb said yesterday that they would begin to provide their cancer drug, Erbitux, to a limited number of colorectal cancer patients who have exhausted other treatment options.